Gene · 186
Papers1,962
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 1,962
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Renal ischemia-reperfusion leads to hypertension and changes in proximal tubule Na+ transport and renin-angiotensin-aldosterone system: Role of NADPH oxidase. | Life Sci | 2021 | 33310030 | PubTator, text mining | PubMed |
| Anti-Hypertensive Potential and Epigenetics of Angiotensin II type 2 Receptor (AT2R). | Curr Hypertens Rev | 2021 | 33302839 | PubTator, text mining | PubMed |
| Targeting ACE2 for COVID-19 Therapy: Opportunities and Challenges. | Am J Respir Cell Mol Biol | 2021 | 33296619 | PubTator, text mining | PubMed |
| Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study. | In Silico Pharmacol | 2021 | 33294307 | PubTator, text mining | PubMed |
| COVID-19's toll on the elderly and those with diabetes mellitus - Is vitamin B12 deficiency an accomplice? | Med Hypotheses | 2021 | 33257090 | PubTator, text mining | PubMed |
| A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19. | Eur J Pharmacol | 2021 | 33227285 | PubTator, text mining | PubMed |
| Association between renin-angiotensin-aldosterone system inhibitor use and COVID-19 hospitalization and death: a 1.4 million patient nationwide registry analysis. | Eur J Heart Fail | 2021 | 33222412 | PubTator, text mining | PubMed |
| Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site. | Br J Cancer | 2021 | 33191407 | PubTator, text mining | PubMed |
| Application of quantitative transcriptomics in evaluating the ex vivo effects of per- and polyfluoroalkyl substances on Atlantic cod (Gadus morhua) ovarian physiology. | Sci Total Environ | 2021 | 33138996 | PubTator, text mining | PubMed |
| Angiotensin-converting enzyme 2 (ACE2): SARS-CoV-2 receptor and RAS modulator. | Acta Pharm Sin B | 2021 | 33072500 | PubTator, text mining | PubMed |
| 2020 update on the renin-angiotensin-aldosterone system in pediatric kidney disease and its interactions with coronavirus. | Pediatr Nephrol | 2021 | 32995920 | PubTator, text mining | PubMed |
| Angiotensin-converting enzyme 2 (ACE2): COVID 19 gate way to multiple organ failure syndromes. | Respir Physiol Neurobiol | 2021 | 32956843 | PubTator, text mining | PubMed |
| AGTR2, One Possible Novel Key Gene for the Entry of SARS-CoV-2 Into Human Cells. | IEEE/ACM Trans Comput Biol Bioinform | 2021 | 32750889 | PubTator, text mining | PubMed |
| Physiological Relevance of Angiotensin Converting Enzyme 2 As a Metabolic Linker and Therapeutic Implication of Mesenchymal Stem Cells in COVID-19 and Hypertension. | Stem Cell Rev Rep | 2021 | 32748331 | PubTator, text mining | PubMed |
| Genomic, transcriptomic, and protein landscape profile of CFTR and cystic fibrosis. | Hum Genet | 2021 | 32734384 | PubTator, text mining | PubMed |
| SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome. | Stem Cell Rev Rep | 2021 | 32691370 | PubTator, text mining | PubMed |
| Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. | Infect Control Hosp Epidemiol | 2021 | 32362297 | PubTator, text mining | PubMed |
| Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases. | Nephrol Dial Transplant | 2021 | 31738409 | PubTator, text mining | PubMed |
| COVID-19 susceptibility: potential of ACE2 polymorphisms. | Egypt J Med Hum Genet | 2020 | 38624559 | PubTator, text mining | PubMed |
| Severe COVID-19: understanding the role of immunity, endothelium, and coagulation in clinical practice. | J Vasc Bras | 2020 | 34211530 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/186/papers?page=34